Hostname: page-component-65b85459fc-bczq6 Total loading time: 0 Render date: 2025-10-17T08:57:26.724Z Has data issue: false hasContentIssue false

Suspected autoimmune encephalitis in the presence of neuropsychiatric symptoms. The importance of differential diagnosis

Published online by Cambridge University Press:  26 August 2025

E. Talaya Navarro*
Affiliation:
Psiquiatría, Complejo Asistencial de Segovia, Segovia, Spain
L. Martín de Francisco Murga
Affiliation:
Psiquiatría, Complejo Asistencial de Segovia, Segovia, Spain
L. Gallardo Borge
Affiliation:
Psiquiatría, Complejo Asistencial de Segovia, Segovia, Spain
M. E. Gómez Fernández
Affiliation:
Psiquiatría, Complejo Asistencial de Segovia, Segovia, Spain
S. N. Pecheykin Pajomov
Affiliation:
Psiquiatría, Complejo Asistencial de Segovia, Segovia, Spain
M. Teijeiro Rebolo
Affiliation:
Psiquiatría, Complejo Asistencial de Segovia, Segovia, Spain
A. Peman Alcazar
Affiliation:
Psiquiatría, Complejo Asistencial de Segovia, Segovia, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Autoimmune encephalitis is a new and increasingly well-described entity. The most common is encephalitis caused by antibodies against the N-methyl-D-aspartate receptor on the surface of neurons (NMDAR encephalitis). It is a predominant entity in women and young patients and it is often associated with ovarian teratomas, neuroblastomas, Hodgkin’s lymphomas and others.

NMDAR encephalitis can manifest with a diverse range of neurological and psychiatric symptoms (personality change, anxiety, insomnia, confusion, attentional and short-term memory deficits, emotional lability, psychotic symptoms, language impairment, fluctuations in the level of consciousness, seizures and dysautonomia).

Objectives

Clinical review of Anti-NMDAR Encephalitis for differential diagnosis with Functional Neurologic Disorder.

Methods

Clinical case and literature review.

Results

We present the clinical case of a 27-year-old woman with a history of depression and anancastic personality disorder. The patient went to the Emergency Department different days presenting both neurological (facial paresthesias, hypoesthesia, weakness, high-intensity occipital headache, dizziness, loss of consciousness and anterograde amnesia) and psychiatric symptoms (obsessive thoughts, anxiety, visual and auditory hallucinations). She was admitted to the Neurology Unit. Complementary tests were performed: EEG, cranial CT scan, MRI, lumbar puncture, blood tests (including tumour markers) and urinalysis, founding no alterations suggestive of encephalitis or other systemic pathologies. She was also evaluated by the Psychiatry service. The patient described that as a result of a recent change in her job she presented emotional lability, obsessive ruminative ideas and anxiety. Treatment with Sertraline 100mg/day and Lorazepam 1mg/8 hours was started.

After ruling out autoimmune encephalitis, the patient was diagnosed with Functional Neurologic Disorder, given the temporal relationship of the symptoms with the stressful history at work.

Conclusions

Given their growing prevalence autoimmune causes, such as NMDA anti-receptor antibody encephalitis, should always be considered in the cases of neuropsychiatric alterations. It is very important to carry out a correct organic screening prior to the diagnosis of psychiatric pathology. It is also essential an adequate coordination between different medical departments for an accurate and comprehensive approach to the patient.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.